Table 3.

Multivariate Cox proportional hazard models for t‐PA as a predictor of endpoints in CAD patients with or without AVSc

	AVSc		Non‐AVSc
t‐PA level	HR (CI)	P value	HR (CI)	P value
Primary endpoint
<1818.71 pg/mL	1	1	1	1
≥1818.71 pg/mL	6.218 [3.168–12.204]	<0.001	2.073 [0.972–4.423]	0.059
Cardiovascular death
<1818.71 pg/mL	1	1	1	1
≥1818.71 pg/mL	6.973 [2.460–19.764]	<0.001	2.734 [0.823–9.081]	0.101
Rehospitalization due to heart failure
<1818.71 pg/mL	1	1	1	1
≥1818.71 pg/mL	5.650 [2.841–11.235]	<0.001	1.833 [0.719–4.676]	0.205
All‐cause mortality
<1818.71 pg/mL	1	1	1	1
≥1818.71 pg/mL	7.626 [2.705–21.498]	<0.001	2.096 [0.751–5.847]	0.157

In Model 2, traditional factors as in Table 2 were adjusted.